Key research foci include smart materials (Adv. Mater.2015, Nature Mater 2014, Nanoscale 2014), drug and gene delivery (Mol. Ther 2015, PLosOne 2014, Small 2013, Mol. Pharmaceutics 2012), and synthetic biology (Artificial Life 2015, Nature Chem 2013, Angew Chem Int Ed. 2012 & 2011).
Current projects are investigating controlled release of therapeutics from synthetic-biopolymer complexes and conjugates, targeted degradable polymers for anti-microbial, drug, gene and cell therapies, and smart materials for protein and cell recognition. Collaborative projects span disciplines including synthetic chemistry, pharmaceutics, cell biology, regenerative medicine, microbial resistance and synthetic biology.
Measures of Esteem
· Royal Society Wolfson Research Merit Award Holder, 2016-
· RSC/SCI Macro Group Medal and Lectureship 2014
· EPSRC Leadership Fellowship - 2009-2014.
· EPSRC Physical Sciences SAT - 2014 -2017.
· Academic Lead - EPSRC Impact Acceleration Account, Nottingham 2012-2015.
· EPSRC Materials Science Strategy Review Panel 2012-2014.
· Head of Division: Drug Delivery and Tissue Engineering, School of Pharmacy 2009-
· Director - EPSRC/AstraZeneca/University of Nottingham Doctoral Training Centre 2006-
· Member of Editorial Board, Journal of Materials Chemistry 2006-2013
· Member of International Advisory Board, Biomaterials Science, 2012-
· Steering Group Member for RSC Review of Chemical Biology, 2007.
· EPSRC Peer Review College 2003--
· Australian Research Council Peer Review College member 2014-
Pharmaceutics lead for Cancers DMP module 2014 and contributor to drug delivery / pharmaceutics modules, Applied Biomolecular Technology MSc
Polymer synthesis, organic magnets, self-assembly of liquid crystalline polymers and molecular imprinting